Granahan Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-49,515
Closed -$1.96M 194
2024
Q4
$1.96M Sell
49,515
-262,466
-84% -$9.94M 0.08% 149
2024
Q3
$10.6M Sell
311,981
-28,166
-8% -$792K 0.42% 74
2024
Q2
$7.37M Sell
340,147
-2,117
-0.6% -$44.5K 0.29% 94
2024
Q1
$7.58M Sell
342,264
-161,634
-32% -$3.94M 0.27% 102
2023
Q4
$13.9M Buy
503,898
+122,574
+32% +$2.96M 0.46% 71
2023
Q3
$8.51M Sell
381,324
-210,358
-36% -$5.41M 0.3% 98
2023
Q2
$15.1M Sell
591,682
-553,845
-48% -$13.4M 0.46% 62
2023
Q1
$25.5M Sell
1,145,527
-617,739
-35% -$14.9M 0.78% 35
2022
Q4
$41.8M Sell
1,763,266
-158,240
-8% -$3.68M 1.28% 20
2022
Q3
$31.9M Sell
1,921,506
-25,497
-1% -$574K 1.04% 25
2022
Q2
$38.7M Sell
1,947,003
-13,733
-0.7% -$277K 1.32% 20
2022
Q1
$54.1M Buy
1,960,736
+166,341
+9% +$4.76M 1.34% 19
2021
Q4
$73.9M Buy
1,794,395
+60,694
+4% +$2.68M 1.52% 13
2021
Q3
$80.5M Sell
1,733,701
-22,376
-1% -$976K 1.53% 15
2021
Q2
$70.2M Buy
1,756,077
+697,340
+66% +$29.8M 1.31% 18
2021
Q1
$56.9M Buy
1,058,737
+517,624
+96% +$29.8M 1.21% 22
2020
Q4
$26.5M Sell
541,113
-194,189
-26% -$9M 0.59% 43
2020
Q3
$23.9M Buy
735,302
+122,549
+20% +$3.9M 0.81% 33
2020
Q2
$15.9M Buy
612,753
+179,114
+41% +$4.46M 0.57% 54
2020
Q1
$10.5M Buy
433,639
+51,682
+14% +$1.3M 0.57% 46
2019
Q4
$10.7M Buy
381,957
+246,907
+183% +$6.39M 0.49% 60
2019
Q3
$3.24M Buy
135,050
+36,856
+38% +$980K 0.18% 111
2019
Q2
$2.8M Buy
+98,194
New +$2.45M 0.14% 119

Other funds holding VCYT

Granahan Investment Management's VCYT Position: Q1 2025 in Review

Granahan Investment Management sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 49,515 shares — an estimated $1.96M sold.

Granahan Investment Management first reported a position in VCYT in Q2 2019 and held it in 23 quarters. The position peaked at $80.5M in Q3 2021. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Granahan Investment Management reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Granahan Investment Management sold 49,515 Veracyte shares in Q1 2025, an estimated $1.96M.
  • Granahan Investment Management first reported a position in Veracyte in Q2 2019 and held it in 23 quarters.
  • Granahan Investment Management's Veracyte position peaked at $80.5M in Q3 2021.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Granahan Investment Management's 13F filing for Q1 2025, filed 15 May 2025.